Method for diagnosis for multiple sclerosis involving anti1-receptor antibody
AssigneeCelltrend GmbH
InventorHarald Heidecke
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for diagnosis of multiple sclerosis (MS) wherein, presence or absence of an anti-AT1 receptor antibody is determined in a sample from a patient to be diagnosed and wherein, the presence of an anti-AT1-receptor antibody is indicative of the disease.
Claims11
A method for complementing the diagnosis of multiple sclerosis in a patient suspected to have multiple sclerosis based on diagnostic criteria comprising obtaining a sample from the patient and performing an immunoassay on the sample to determine the presence or absence of an anti-AT1 receptor antibody in the sample, wherein the presence of an anti-AT1-receptor antibody is indicative of multiple sclerosis, and wherein the patient is human.
A method for complementing the diagnosis of multiple sclerosis in a patient suspected to have multiple sclerosis based on diagnostic criteria comprising obtaining serum from the patient and performing a cellular ELISA on the serum to determine the presence or absence of an anti-AT1 receptor antibody in the serum, wherein the presence of an anti-AT1-receptor antibody is indicative of multiple sclerosis, and wherein the patient is human.
Dependencies are inferred from the claim text.